The Dow, the S&P 500, and the Nasdaq all slipped through mid-afternoon trading on Friday after posting three straight days of gains for the first time in a month. In fact, the Dow even technically jumped into a new bull market Thursday, just three days after reaching its bea
I believe that we are amid one of the greatest buying opportunities of our lifetimes.It’s no secret that the financial world has been turned upside down by the novel coronavirus, which slowed down economies across the globe. Investment decisions have been driven by panic over
A month has gone by since the last earnings report for Curtiss-Wright (CW). Shares have lost about 20.1% in that time frame, underperforming the S&P 500.
It has been about a month since the last earnings report for Sarepta Therapeutics (SRPT). Shares have lost about 8% in that time frame, outperforming the S&P 500.
It has been about a month since the last earnings report for Horizon Therapeutics (HZNP). Shares have lost about 16.6% in that time frame, underperforming the S&P 500.
A month has gone by since the last earnings report for Universal Health Services (UHS). Shares have lost about 28.4% in that time frame, underperforming the S&P 500.
A month has gone by since the last earnings report for Global Blood Therapeutics (GBT). Shares have lost about 15% in that time frame, underperforming the S&P 500.
A month has gone by since the last earnings report for Callon Petroleum (CPE). Shares have lost about 67.4% in that time frame, underperforming the S&P 500.
It has been about a month since the last earnings report for Nutanix (NTNX). Shares have lost about 24.4% in that time frame, underperforming the S&P 500.
A month has gone by since the last earnings report for Acadia Pharmaceuticals (ACAD). Shares have added about 1.1% in that time frame, outperforming the S&P 500.
A month has gone by since the last earnings report for National Vision (EYE). Shares have lost about 37% in that time frame, underperforming the S&P 500.
It has been about a month since the last earnings report for Aegion (AEGN). Shares have lost about 17.4% in that time frame, underperforming the S&P 500.